Skip to main content
. 2020 Sep 19;54:114–120. doi: 10.1016/j.breast.2020.09.006

Fig. 2.

Fig. 2

Comparative analysis for the prognosis in regard to molecular subtypes including luminal A (a), luminal B (b), HER2 enriched (c), and triple-negative breast cancer (d). IDC = ductal breast cancer; Special = special histologic breast cancer; TN = triple-negative breast cancer.